Bel Fuse Earnings: What To Look For From BELFA

Bel Fuse (NASDAQ: BELFA) is set to report earnings Wednesday. The company last quarter posted revenue of $178.5 million, up 17.2% year on year, beating revenue and EPS expectations, and issued next-quarter guidance above analysts’ estimates. For the upcoming quarter, analysts expect revenue growth of 23.2% y/y. The article cites an average analyst price target of $322 versus a $226.25 share price.

Original reporting
Published Jul 28, 2026, 5:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 5:51 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Bel Fuse Earnings: What To Look For From BELFA — source image
Decision brief

The 30-second read

$BELFANeutralMed
01

Why it matters

Traders can use the stated consensus growth rate (23.2% YoY) and the company’s recent beat/guidance history to frame scenarios for revenue and EPS versus expectations.

02

Market read

Provides earnings timing, recent beat/guidance context, and consensus growth expectations, which can inform positioning into the print.

03

What to watch

The article does not mention margins, backlog, or order trends, which are often the key swing factors for electrical connector and systems suppliers into earnings.

Relevance 5/10Novelty 5/10Timing: ahead of Wednesday afternoon earnings

Background

The piece is a pre-earnings checklist for Bel Fuse, referencing last quarter’s revenue beat and guidance strength, plus consensus expectations for the upcoming quarter.

Company-level read

Ticker impact

$BELFANeutralMedium confidence
Context

Bel Fuse is set to report earnings Wednesday afternoon, with prior-quarter revenue and EPS beats and next-quarter guidance exceeding expectations.

Expected impact

Likely elevated pre- and post-earnings volatility; direction depends on whether revenue growth and guidance re-accelerate versus the 23.2% YoY expectation.

Evidence & confidence

The article provides concrete earnings timing plus recent beat and guidance context, but it does not disclose any new, incremental datapoint beyond what is already framed for the upcoming print.

Market effects

Electrical equipment peers’ recent results (Allegion, Teledyne) are used as read-across, implying sector-wide expectations may be reset around similar demand signals.

None specified.

None specified.

Counterpoint

If BELFA’s guidance and EPS beat last quarter were driven by temporary factors, the stock could underperform even with a modest beat versus slowing YoY growth expectations.

Key entities

  • Bel Fuse

    NASDAQ-listed electronic system and device provider scheduled to report earnings Wednesday afternoon.

  • Allegion

    Electrical equipment peer cited for Q2 revenue growth and post-results stock reaction.

  • Teledyne

    Electrical equipment peer cited for Q2 revenue growth and stock reaction.

Related articles

$BELFAMedAI 8/10

Bel Fuse’s (NASDAQ:BELFA) Q2 CY2026 Sales Top Estimates, Guides for Strong Sales Next Quarter

Bel Fuse (NASDAQ: BELFA) reported Q2 CY2026 revenue of $210.7 million, up 25.2% year over year, topping Wall Street estimates. Management guided next-quarter revenue to $215 million at the midpoint, above analyst expectations. Non-GAAP EPS was $2.76, up from $1.58 a year earlier, and ahead of consensus. The company said it raised net proceeds of $441.6 million to pay down debt and fund Enercon-related plans.

$CRCLMed

Here Are Monday’s Best Wall Street Analyst Research Calls: Atmos Energy, Best Buy, Biogen, Capital One, Costco, Disney, Papa John’s International, Shopify, and More

The article lists Monday analyst calls and market moves. It highlights SK hynix’s Nasdaq debut, up about 12.8% to $168.01 after raising nearly $26.5B. It cites upgrades including BIIB to Buy at $235, COF to Buy at $229, and SHOP to Buy at $160, plus downgrades like BBY to Hold. Circle (CRCL) rose ~15% on OCC approval.

$MATVMed

Mativ Q2 Earnings Call Highlights

Mativ (NYSE:MATV) reported Q2 adjusted EBITDA of $50 million, up more than 18%, and segment margin up 210 bps to 15.3% as pricing offset inflation. Healthcare operations at its Knoxville facility normalized after an outage. Net debt fell to $908 million and net leverage improved to 3.8x. A Menasha, Wisconsin tornado is expected to cut Q3 sales by $20M to $25M.

$MAINMed

Main Street Capital Q2 Earnings Call Highlights

Main Street Capital (NYSE:MAIN) reported Q2 results on an earnings call. Total investment income was $149.6M (+3.9% YoY, +6.8% QoQ). DNII before taxes was $1.08/share; CFO expects at least $0.97/share in Q3. The board declared a $0.30 supplemental dividend and regular monthly dividends of $0.265/share. MAIN invested about $100M in lower middle market deals and $239M in private loans.